Treatment-related noninfectious AEs CTCAE grade 3 or higher
| Type of AE . | Total (n = 75) . |
|---|---|
| Blood and lymphatic system disorders, % (n) | |
| Anemia | 4 (3) |
| Leukopenia | 4 (3) |
| Lymphopenia | 8 (6) |
| Neutropenia | 1 (1) |
| Thrombocytopenia | 7 (5) |
| Hepatobiliary disorders | |
| Alanine aminotransferase increased | 3 (2) |
| Alkaline phosphatase increased | 1 (1) |
| Aspartate aminotransferase increased | 1 (1) |
| Hyperbilirubinemia | 9 (7) |
| Psychiatric disorders | |
| Anxiety | 1 (1) |
| Depression | 1 (1) |
| Vascular disorders | |
| Hypertension | 1 (1) |
| Hypotension | 1 (1) |
| Metabolism disorders | |
| Hypocalcemia | 3 (2) |
| Hyponatremia | 1 (1) |
| Nervous system disorders | |
| Somnolence | 1 (1) |
| PML | 0 (0) |
| General disorders | |
| Weakness/fatigue | 4 (3) |
| Type of AE . | Total (n = 75) . |
|---|---|
| Blood and lymphatic system disorders, % (n) | |
| Anemia | 4 (3) |
| Leukopenia | 4 (3) |
| Lymphopenia | 8 (6) |
| Neutropenia | 1 (1) |
| Thrombocytopenia | 7 (5) |
| Hepatobiliary disorders | |
| Alanine aminotransferase increased | 3 (2) |
| Alkaline phosphatase increased | 1 (1) |
| Aspartate aminotransferase increased | 1 (1) |
| Hyperbilirubinemia | 9 (7) |
| Psychiatric disorders | |
| Anxiety | 1 (1) |
| Depression | 1 (1) |
| Vascular disorders | |
| Hypertension | 1 (1) |
| Hypotension | 1 (1) |
| Metabolism disorders | |
| Hypocalcemia | 3 (2) |
| Hyponatremia | 1 (1) |
| Nervous system disorders | |
| Somnolence | 1 (1) |
| PML | 0 (0) |
| General disorders | |
| Weakness/fatigue | 4 (3) |